Regulation of T-Lymphocyte CCL3 and CCL4 production by retinal pigment epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 1, 2013, Pages 722-730

  Wallace, Carol A ^a   Moir, Gill ^a   Malone, David F G ^a   Duncan, Linda ^a   Devarajan, Gayathri ^a   Crane, Isabel J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; NORMAL HUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, NEUTRALIZING; CELLS, CULTURED; CHEMOKINE CCL3; CHEMOKINE CCL4; COCULTURE TECHNIQUES; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INDOMETHACIN; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE ACTIVATION; RETINAL PIGMENT EPITHELIUM; T-LYMPHOCYTES;

EID: 84874695682     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10602     Document Type: Article

References (54)

1. Liversidge J, Forrester JV. Regulation of immune responses by the retinal pigment epithelium. In: Marmor MF, Wolfensberger TJ, eds. The Retinal Pigment Epithelium. Current Aspects of Function and Disease. New York: Oxford University Press; 1998:511-541.
2. Holtkamp GM, Kijlstra A, Peek R, De Vos AF. Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res. 2001;20: 29-48.
3. Liversidge J, McKay D, Mullen G, Forrester JV. Retinal pigment epithelial cells modulate lymphocyte function at the bloodretina barrier by autocrine PGE2 and membrane-bound mechanisms. Cell Immunol. 1993;149:315-330.
4. Liversidge J, Grabowski P, Ralston S, Benjamin N, Forrester JV. Rat retinal pigment epithelial cells express an inducible form of nitric oxide synthase and produce nitric oxide in response to inflammatory cytokines and activated T cells. Immunology. 1994;83:404-409.
5. Gregerson DS, Heuss ND, Lew KL, McPherson SW, Ferrington DA. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy. Invest Ophthalmol Vis Sci. 2007; 48:4654-4663.
6. Ishida K, Panjwani N, Cao Z, Streilein JW. Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms. Ocul Immunol Inflamm. 2003;11:91-105.
7. Kaestel CG, Jørgensen A, Nielsen M, et al. Human retinal pigment epithelial cells inhibit proliferation and IL2R expression of activated T cells. Exp Eye Res. 2002;74:627-637.
8. Kaestel CG, Lovato P, Odum N, Nissen MH, Ropke C. The immune privilege of the eye: human retinal pigment epithelial cells selectively modulate T-cell activation in vitro. Curr Eye Res. 2005;30:375-383.
9. Xu H, Manivannan A, Liversidge J, Sharp PF, Forrester JV, Crane IJ. Requirements for passage of T lymphocytes across noninflamed retinal microvessels. J Neuroimmunol. 2003;142:47-57.
10. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Ann Rev Immunol. 2004;22:891-928.
11. Ishikawa K, Yoshida S, Kadota K, et al. Gene expression profile of hyperoxic and hypoxic retinas in a mouse model of oxygeninduced retinopathy. Invest Ophthalmol Vis Sci. 2010;51: 4307-4319.
12. Yoshida S, Yoshida A, Ishibashi T, Elner SG, Elner VM. Role of MCP-1 and MIP-1 alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization. J Leukocyte Biol. 2003;73:137-144.
13. Crane IJ, McKillop-Smith S, Wallace CA, Lamont GR, Forrester JV. Expression of the chemokines MIP-1a, MCP-1 and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2001;42:1547-1552.
14. Foxman EF, Zhang MF, Hurst SD, et al. Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1-versus Th2-mediated ocular inflammation. J Immunol. 2002;168:2483-2492.
15. Schrum S, Probst P, Fleischer B, Zipfel PF. Synthesis of the CCchemokines MIP-1a, MIP-1b and RANTES is associated with a type 1 immune response. J Immunol. 1996;157:3598-3604.
16. Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 2002;13:455-481.
17. Natori Yu, Sekiguchi M, Ou Z, Natori Ya. Gene expression of CC chemokines in experimental crescentic glomerulonephritis (CGN). Clin Exp Immunol. 1997;109:143-148.
18. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunol Today. 1994;15:127-133.
19. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD. An important role for the chemokine macrophage inflammatory protein-1a in the pathogenesis of the T cellmediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol. 1995;155:5003-5010.
20. Crane IJ, Xu H, Manivannan A, et al. Effect of anti-macrophage inflammatory protein-1a on leukocyte trafficking and disease progression in experimental autoimmune uveoretinitis. Eur J Immunol. 2003;33:402-410.
21. Saha K, Bentsman G, Chess L, Volsky DJ. Endogenous production of beta-chemokines by CD4+, but not CD8+, Tcell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with nonsyncytium-inducing HIV-1 in vitro. J Virol. 1998;72:876-881.
22. Barabitskaja O, Foulke JS, Pati S, Bodor J, Reitz MS. Suppression of MIP-1 beta transcription in human T cells is regulated by inducible cAMP early repressor (ICER). J Leukocyte Biol. 2006;79:378-387.
23. Garzino-Demo A, Moss RB, Margolick JB, et al. Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status. Proc Natl Acad Sci U S A. 1999;96:11986-11991.
24. Wang HW, Babic AM, Mitchell HA, Liu K, Wagner DD. Elevated soluble ICAM-1 levels induce immune deficiency and increase adiposity in mice. FASEB J. 2005;19:1018-1020.
25. Crane IJ, Kuppner MC, McKillop-Smith S, Knott RM, Forrester JV. Cytokine regulation of RANTES production by human retinal pigment epithelial cells. Cell Immunol. 1998;184:37-44.
26. Mesri M, Liversidge J, Forrester JV. ICAM-1/LFA-1 interactions in T-lymphocyte activation and adhesion to cells of the bloodretina barrier in the rat. Immunology. 1994;83:52-57.
27. Laneuville O, Breuer DK, Dewitt DL, Hla T, Funk CD, Smith WL. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and-2 by non-steroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 1994;271:927-934.
28. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Meth. 1995;184: 39-51.
29. Zielasek J, Jung S, Gold R, Liew FY, Toyka KV, Hartung HP. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J Neuroimmunol. 1995;58:81-88.
30. Nagineni CN, Kutty RK, Detrick B, Hooks JJ. Inflammatory cytokines induce intercelluar adhesion molecule-1 (ICAM-1) mRNA synthesis and protein secretion by human retinal pigment epithelial cell cultures. Cytokine. 1996;8:622-630.
31. Hooks JJ, Nagineni CN, Hooper LC, Hayashi K, Detrick B. IFNbeta provides immuno-protection in the retina by inhibiting ICAM-1 and CXCL9 in retinal pigment epithelial cells. J Immunol. 2008;180:3789-3796.
32. Giovannetti A, Quinti I, Rainaldi L, et al. Proliferative responses to PHA, anti-CD3 and antigens in patients with lymphoproliferative disease of granular lymphocytes-mannoproteins of Candida albicans induce proliferation and cytotoxicity. Acta Haematol. 1997;98:65-71.
33. Jorgensen A, Wiencke AK, La Cour M, et al. Human retinal pigment epithelial cell-induced apoptosis in activated T cells. Invest Ophthalmol Vis Sci. 1998;39:1590-1599.
34. Farrokh-Siar L, Rezai KA, Semnani RT, et al. Human fetal retinal pigment epithelial cells induce apoptosis in the T cell line Jurkat. Invest Ophthalmol Vis Sci. 1999;40:1503-1511.
35. Goureau O, Hicks D, Courtois Y. Human retinal pigmented epithelial cells produce nitric oxide in response to cytokines. Biochem Biophys Res Comm. 1994;198:120-126.
36. Kutty RK, Kutty G, Hooks JJ, Wiggert B, Nagineni CN. Transforming growth factor-b inhibits the cytokine-mediated expression of the inducible nitric oxide synthase mRNA in human retinal pigment epithelial cells. Biochem Biophys Res Comm. 1995;215:386-393.
37. Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA. Antiinflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol. 2009;9:447-453.
38. Tripathi P, Tripathi P, Kashyap L, Singh V. The role of nitric oxide in inflammatory reactions. FEMS Immunol Med Microbiol. 2007;51:443-452.
39. Sherry B, Schmidtmayerova H, Zybarth G, Dubrovsky L, Raabe T, Bukrinsky M. Nitric oxide regulates MIP-1 alpha expression in primary macrophages and T lymphocytes: implications for anti-HIV-1 response. Mol Med. 2000;6:542-549.
40. Kim JY, Kim D, Lee EM, et al. Inducible nitric oxide synthase inhibitors prolonged the survival of skin xenografts through selective down-regulation of pro-inflammatory cytokine and CC-chemokine expressions. Transpl Immunol. 2003;12:63-72.
41. Sreeramkumar V, Fresno M, Cuesta N. Prostaglandin E-2 and T cells: friends or foes? Immunol Cell Biol. 2012;90:579-586.
42. van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med. 1996;74:13-33.
43. Shi Q, Benderdour M, Lavigne P, Ranger P, Fernandes JC. Evidence for two distinct pathways in TNF alpha-induced membrane and soluble forms of ICAM-1 in human osteoblastlike cells isolated from osteoarthritic patients. Osteoarthritis Cartilage. 2007;15:300-308.
44. Hashimoto M, Shingu M, Ezaki I, et al. Production of soluble ICAM-1 from human endothelial-cells induced by IL-1-beta and TNF-alpha. Inflammation. 1994;18:163-173.
45. Keating SM, Clark KR, Stefanich LD, et al. Competition between intercellular adhesion molecule-1 and a smallmolecule antagonist for a common binding site on the alpha 1 subunit of lymphocyte function-associated antigen-1. Protein Sci. 2006;15:290-303.
46. Rieckmann P, Michel U, Albrecht M, Bruck W, Wockel L, Felgenhauer K. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol. 1995;60:9-15.
47. Esser P, Bresgen M, Heimann K, Wiedemann P. Intercellularadhesion molecule-1 (ICAM-1) levels in plasma and vitreous from patients with vitreoretinal disorders. Invest Ophthalmol Vis Sci. 1994;35:2039.
48. Perez OD, Mitchell D, Jager GC, et al. Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1. Nat Immunol. 2003;4:1083-1092.
49. Varga G, Nippe N, Balkow S, et al. LFA-1 contributes to signal I of T-cell activation and to the production of T(h)1 cytokines. J Invest Dermatol. 2010;130:1005-1012.
50. Murphy A, Long A, Volkov Y, Kelleher D. Cross-linking of LFA-1 induces secretion of macrophage inflammatory protein (MIP)-1a and MIP-1b with consequent directed migration of activated lymphocytes. Eur J Immunol. 2000;30:3006-3011.
51. Volkov Y, Long A, Kelleher D. Inside the crawling T cell: Leukocyte function-associated antigen-1 cross-linking is associated with microtubule-directed translocation of protein kinase C isoenzymes b(I) and d. J Immunol. 1998;161:6487-6495.
52. Roescher N, Vosters JL, Yin HE, Illei GG, Tak PP, Chiorini JA. Effect of soluble ICAM-1 on a Sjogren's syndrome-like phenotype in NOD mice is disease stage dependent. PLoS One. 2011;6:e19962.
53. Sharma V, Xu M, Ritter LM, Wilkie NM. HIV-1 tat induces the expression of a new hematopoietic cell-specific transcription factor and downregulates MIP-1 alpha gene expression in activated T-cells. Biochem Biophys Res Comm. 1996;223:526-533.
54. Khuu CH, Barrozo RM, Hai T, Weinstein SL. Activating transcription factor 3 (ATF3) represses the expression of CCL4 in murine macrophages. Mol Immunol. 2007;44:1598-1605.